What Semen Can Tell You About a Man's Health

Semen can provide a window into a man's testicular and reproductive health, but it is not a general health panel. A semen analysis measures ejaculate volume and sperm concentration, total number, motility, morphology and, when indicated, vitality. An unusual pattern can justify reviewing the testes, hormones, genital tract, medicines, recent fever or exposures. It cannot by itself predict fertility, testosterone, cardiovascular risk or lifespan.

That distinction matters even when fatherhood is not being considered. The clinical value is not in labelling someone “fertile” or “infertile”. It is in asking which question the result opens and what proportionate assessment can answer it.

What semen analysis measures—and the question behind each result

Parameter	What it describes	What a persistent change may prompt clinicians to review	What it cannot diagnose alone
Volume	Total ejaculate, mostly contributed by the seminal vesicles and prostate	Incomplete collection, short abstinence, retrograde ejaculation, obstruction or androgen environment	Prostate function, testosterone or fertility
Concentration and total count	Sperm per millilitre and across the entire ejaculate	Testicular production, volume, varicocele, testicular history, fever, medicines, androgens, toxins or gonadotoxic therapy	The exact cause or ability to conceive
Motility	The proportions that move and move progressively	Sperm maturation, sample handling, recent illness, inflammation or other factors if confirmed	Infection, oxidative stress or a specific systemic risk
Morphology	Percentage meeting strict microscopic shape criteria	Combined interpretation and laboratory quality control	“Defective sperm”, genetics or infertility in isolation
Vitality	Proportion of live sperm	Whether immotile sperm are alive when more than 60% are immotile	Overall health or complete reproductive potential

Total sperm number combines concentration and volume. A concentration that looks preserved can therefore coexist with a low total output when volume is small. Low volume may also mean that the first, sperm-rich fraction was lost during collection. Collection comes before endocrine or genetic speculation.

How to read WHO reference values without turning them into a diagnosis

Characteristic	WHO 2021 lower reference limit	Correct interpretation
Volume	1.4 mL	Fifth percentile of the reference population
Concentration	16 million/mL	Not a biological boundary
Total sperm number	39 million per ejaculate	Often more informative than concentration alone
Total motility	42%	Progressive plus non-progressive movement
Progressive motility	30%	Interpret alongside number and sample quality
Vitality	54% live	Mainly indicated when more than 60% are immotile
Normal forms	4%	Strict criteria; the remainder are not automatically useless

These values came from men in 12 countries whose partners achieved a natural conception within 12 months. Five per cent fell below each lower limit despite belonging to that reference population. Conversely, sitting above a limit does not guarantee pregnancy or perfect testicular health. EAU and AUA/ASRM guidance is explicit: no individual semen parameter precisely distinguishes fertile from infertile men.

Morphology shows why. Four per cent “normal forms” under strict criteria does not mean 96% of sperm are incapable of functioning. Observer variation matters, and the result gains meaning only alongside count, motility, history and, when reproduction is the question, the other partner's context.

Preparation and collection: the protocol is part of the result

1. Use a laboratory following WHO methods and quality control. Concentration, motility and morphology require technique; a home counter usually answers a much narrower question.
2. Record 2–7 days without ejaculation. This is WHO's operational interval for diagnostic testing. Longer intervals tend to increase count and may lower the mobile proportion; shorter intervals may lower count. Use comparable conditions if a repeat is needed.
3. Collect the complete ejaculate into the supplied container. Report any loss, especially of the first fraction. Do not use an ordinary latex condom or lubricant unless the laboratory provides a validated non-spermicidal product.
4. Control time and temperature. WHO prefers examination to start within 30 minutes and no later than 60. Follow the laboratory's transport instructions and avoid cooling or heating the sample.
5. Record factors that may change interpretation. Recent fever or illness, genitourinary infection, surgery, medicines, testosterone or anabolic steroids, chemotherapy, radiotherapy and incomplete collection matter more than trying to “optimise” the sample.

The 2–7-day interval is not advice about the healthiest sexual frequency. It is an imperfect attempt to standardise testing. WHO's sixth edition recognises that abstinence itself introduces variability; recording it is more useful than chasing one ideal number.

What an altered pattern may reveal about a man's health

Testicular production and the hormonal environment

A persistently very low count or no sperm in the ejaculate may reflect reduced testicular production, obstruction or hormonal suppression. A history of undescended testes, torsion, trauma, surgery, chemotherapy, radiotherapy or infection changes the probabilities. Examination adds testicular volume and consistency, epididymis and vas deferens, varicocele, body hair and gynaecomastia.

Semen analysis does not replace an assessment for low testosterone and hypogonadism. With oligozoospermia or azoospermia, EAU guidance recommends total testosterone, FSH and LH to help distinguish impaired testicular production from altered hormonal signalling. In other settings, hormones are added only when symptoms and signs justify them.

Medicines and exposures

Exogenous testosterone and anabolic steroids can suppress LH and FSH and markedly reduce sperm production, sometimes to azoospermia. Recovery after withdrawal can take months and is not identical for every man. Do not stop or substitute treatment without clarifying indication, dose, duration and goals with a clinician.

Some cancer treatments are gonadotoxic. Other medicines, recreational drugs, occupational heat, smoking and environmental exposures may belong in the history. One result cannot identify which factor is responsible or turn a lifestyle change into proven therapy. The priority is to remove avoidable exposures safely and treat recognised causes, not to buy an antioxidant stack.

Ducts, glands and ejaculation

Persistently low volume, particularly with acidic pH and azoospermia or severe oligozoospermia, can suggest distal obstruction. Absent vas deferens opens a specific genetic work-up; retrograde ejaculation raises another question. Volume alone cannot distinguish them. History, examination and, when indicated, post-ejaculatory urine, imaging or genetics do.

A systemic signal, but not yet a predictive test

The newest Danish cohort followed 78,284 men assessed because of reported couple infertility between 1965 and 2015. During a median 23 years, 8,600 men died. Men with a total motile sperm count above 120 million had a calculated life expectancy of 80.3 years, compared with 77.6 years among those with more than 0 to 5 million; in the period with richer clinical data, the adjusted mortality hazard ratio for the latter group was 1.61.

The 2.7-year difference does not predict one man's lifespan. This was a selected clinical cohort spanning five decades of changing laboratory practice and healthcare, without health-behaviour data. It cannot establish whether semen quality is cause, consequence, a shared marker or a mixture.

A systematic review of 21 studies judged every study at high or unclear risk of bias. Signals were more consistent in azoospermia, yet the authors concluded that evidence is insufficient to use semen analysis as a predictor of poor long-term health, especially in the general population. The responsible translation is “do not ignore the man after a confirmed abnormal result”, not “take a semen test to learn how long you will live”.

Decision table: when semen analysis opens a health conversation

Situation	Proportionate next step	What to avoid
No symptoms, no relevant history and no reproductive question	Continue routine prevention based on age and risk	Using semen as a universal health or longevity screen
One mildly low parameter in one sample	Review collection, abstinence, illness and medicines; repeat if it will change a decision	Labelling infertility or buying supplements
Confirmed abnormality in two samples	Medical and reproductive history, andrology examination and directed tests	Ordering indiscriminate panels without a hypothesis
Azoospermia or concentration below 5 million/mL	Andrology assessment without unnecessary delay; hormones and genetics according to the pattern	Assuming it is irreversible or explained only by testosterone
Low volume + acidic pH + very low or absent count	Review sample loss, retrograde ejaculation and obstruction; image only when indicated	Diagnosing “prostate disease” from the report
Testosterone, anabolic steroid or gonadotoxic-treatment exposure	Review indication, exposure, goals and options with endocrinology or urology	Stopping abruptly or self-medicating to “restart” production
Pain, lump, testicular change, fever or persistent blood	Prioritised clinical assessment according to the red flag	Waiting months for another semen analysis

Tests that may accompany it—and tests that are not routine

• History and examination: they are part of the test, not an optional extra. Puberty, sexual function, medicines, operations, infections, family history, testes and varicocele all matter.
• FSH, LH and total testosterone: particularly useful in oligozoospermia or azoospermia and with endocrine signs. Testosterone needs its own confirmation protocol.
• Genetics: reserved for patterns such as azoospermia, a very low count or absent vas deferens; findings may affect the man and offspring and require counselling.
• Ultrasound: should answer an anatomical question or clarify examination, not compensate for an incomplete history.
• Sperm DNA fragmentation: it is not a general marker of “age” or a first-line test for everyone. Guidelines reserve it for selected reproductive scenarios.
• Oxidative-stress and microbiology tests: are not automatic. White cells or symptoms may justify a focused investigation, but do not establish infection alone.

The same rule applies to other longevity biomarkers: testing is useful when the number answers a question and comes with an action rule. A personalised health protocol is not the biggest panel. It is the smallest set of information that clarifies a decision and supports reassessment.

Risks, common mistakes and red flags

• Self-diagnosis: an app or home test may estimate count or motility but cannot reproduce the full assessment or explain a cause.
• Treating the report: high-dose supplements, hormones and online products may interact, be contaminated or delay a treatable condition.
• Chasing a perfect sample: sleep, diet, movement and not smoking matter for their established benefits. No habit guarantees a normal semen analysis.
• Ignoring ordinary prevention: blood pressure, lipids, glucose, vaccination, physical activity and sleep are not replaced by a normal sample.

Sudden severe testicular pain, a hard lump or new enlargement, significant trauma, fever with a red painful scrotum, or inability to pass urine require urgent or same-day care. Blood in semen is often benign, but persistent or recurrent bleeding—especially with blood in urine, pain, fever, weight loss or a mass—deserves assessment rather than waiting for routine retesting.

Sleep, metabolic health, stress and habits belong in the context, but should not become a universal explanation. At Progevita, the useful sequence is to listen, measure when there is a question, interpret alongside the history and adjust over time. Semen may begin that conversation; it should not take it over.

Frequently asked questions about semen and men's health

Does a normal semen analysis prove that a man is healthy?

No. It describes one sample and selected reproductive functions. It does not rule out hypertension, diabetes, cardiovascular disease, cancer or other conditions; prevention is based on age, symptoms, history and risk.

Does an abnormal result mean infertility?

No. WHO limits are percentiles, not a boundary. The whole pattern, persistence and both partners' reproductive context matter.

Is testing worthwhile if I do not want children?

There is no recommended universal screen for asymptomatic men. It may be useful with symptoms, testicular history, gonadotoxic exposure, androgen use or a specific clinical question.

Can it diagnose low testosterone?

No. Hypogonadism requires symptoms or signs, two reliable morning testosterone results and assessment of the cause. Semen may be one part, not the diagnosis.

How many days of abstinence are needed?

WHO specifies 2–7 days to standardise a diagnostic sample. Record the interval and follow the laboratory's instructions; it is not sexual-health advice.

When should it be repeated?

EAU guidance recommends at least two analyses when the first is abnormal. Timing depends on collection, severity and whether fever, illness or a modifiable exposure was present.

What does 4% normal morphology mean?

It is the fifth percentile under strict criteria. It does not mean 96% are useless and cannot establish infertility on its own.

Do testosterone and anabolic steroids alter the result?

Yes. They can suppress the hormonal signals that sustain sperm production. Recovery can take months, and any change should be clinically coordinated.

Sources

1. World Health Organization. WHO laboratory manual for the examination and processing of human semen, sixth edition. 2021.
2. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Male Infertility. Accessed 29 September 2026.
3. American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men. 2024 amendment.
4. Priskorn L et al. Semen quality and lifespan: 78,284 men followed for up to 50 years. Human Reproduction. 2025.
5. Nedelcu S et al. Lab-based semen parameters as predictors of long-term health in men: a systematic review. Human Reproduction Open. 2024.
6. Eisenberg ML et al. Semen quality, infertility and mortality in the USA. Human Reproduction. 2014.

Method: Spanish and English SERPs, the WHO manual, clinical guidelines and linked studies were reviewed on 29 September 2026. Mortality associations come from men assessed for reproductive problems and are not presented as individual prognosis. We will update this page if WHO procedures or andrology recommendations change.

If a symptom, history or result has opened a question about your health, you can request an initial assessment with the Progevita team. The goal is not more testing; it is deciding which test may clarify the question and which would only add noise.